PNEUMOSTOMA MANAGEMENT METHOD FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

• US 20090205645A1
• Filed: 02/18/2009
• Published: 08/20/2009
• Est. Priority Date: 02/19/2008
• Status: Abandoned Application

• Current Assignee: Portaero, Inc
• Original Assignee: Portaero, Inc
• Inventors: Tanaka, Don, Cerier, Jeffrey C., Evans, Stephen C., Wiesman, Joshua P., Plough, David C., Boseck, Gary L., Abraham, Richard A.
• Application Number:
  US12/388,451
• Publication Number:
  US 20090205645A1
• Time in Patent Office: Days
• US Class Current: 128/200.240
• CPC Class Codes: A61B 2017/00809 Lung operations
• CPC Class Codes: A61K 9/007 Pulmonary tract; Aromatherapy
• CPC Class Codes: A61M 1/04 Artificial pneumothorax apparatus
• CPC Class Codes: A61M 11/00 Sprayers or atomisers specially adapted for therapeutic purposes in general B05B; aerosol containers B65D83/14
• CPC Class Codes: A61M 11/005 using ultrasonics spraying or atomising liquids using ultrasonic vibrations in general B05B17/06
• CPC Class Codes: A61M 11/042 electrical
• CPC Class Codes: A61M 13/00 Insufflators for therapeutic or disinfectant purposes , i.e. devices for blowing a gas, powder or vapour into the body hand-held units in which gas flow is produced by muscular energy at the moment of use B05B11/062
• CPC Class Codes: A61M 15/0085 using ultrasonics spraying or atomising liquids using ultrasonic vibrations in general B05B17/06
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 15/02 with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
• CPC Class Codes: A61M 16/0816 Joints or connectors
• CPC Class Codes: A61M 16/0833 T- or Y-type connectors, e.g. Y-piece
• CPC Class Codes: A61M 16/202 electrically actuated
• CPC Class Codes: A61M 2039/0252 for access to the lungs
• CPC Class Codes: A61M 2039/0276 for introducing or removing fluids into or out of the body
• CPC Class Codes: A61M 2202/0208 Oxygen
• CPC Class Codes: A61M 2202/025 Helium
• CPC Class Codes: A61M 2202/064 Powder
• CPC Class Codes: A61M 2205/075 Bulb type
• CPC Class Codes: A61M 2205/7518 bacterial
• CPC Class Codes: A61M 2205/7536 : allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
• CPC Class Codes: A61M 25/02 : Holding devices, e.g. on the body
• CPC Class Codes: A61M 25/04 : in the body, e.g. expansible A61M25/10, A61M16/0488 take precedence
• CPC Class Codes: A61M 25/10 : Balloon catheters A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02; inflatable balloons for placing stents or stent-grafts A61F2/958 ; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00
• CPC Class Codes: A61M 27/00 : Drainage appliance for wounds or the like , i.e. wound drains, implanted drains negative pressure wound therapy devices A61M1/90; implements for holding wound open A61B17/02 ; middle ear drainage A61F11/202
• CPC Class Codes: A61M 39/02 : Access sites
• CPC Class Codes: A61M 39/0247 : Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body peritoneal dialysis catheters A61M1/285; tracheostomy devices A61M16/0465; measuring pressure within the body A61B5/03; colostomy devices A61F5/445; gastrotomy feeding tubes A61J15/0015; means for fixing a feeding tube outside of the body A61J15/0053

Abstract

A method for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. To use the system, the chest is first cleaned and the chest mount secured to the chest adjacent the pneumostoma. The pneumostoma vent is then inserted into the pneumostoma through an aperture in the chest mount until it is engaged and secured by a coupling of the chest mount. The pneumostoma vent may be replaced periodically such as daily. The chest mount may be changed less frequently such as weekly.

Claims

1. A method to control material entering and exiting a pneumostoma on a chest of a patient using a disposable pneumostoma management system having a chest mount and a pneumostoma vent wherein the method comprises:

(a) securing the chest mount to the chest of the patient using an adhesive such that an aperture of the chest mount is aligned with the pneumostoma;

(b) inserting the pneumostoma vent through the aperture of the chest mount into the pneumostoma and securing the pneumostoma vent to the chest mount;

(c) removing the pneumostoma vent from the pneumostoma through the aperture of the chest mount and inserting a second pneumostoma vent through the aperture of the chest mount into the pneumostoma and securing the second pneumostoma vent to the chest mount.

2. The method of claim 1, further comprising the step of:

(d) removing the chest mount from the chest of the patient after step (c) and no sooner than two days after securing the chest mount to the chest of the patient.

3. The method of claim 1, wherein approximately one day passes between step (b) and step (c).

4. The method of claim 1, wherein step (c) comprises:

(c1) removing the pneumostoma vent from the pneumostoma through the aperture of the chest mount and inserting a second pneumostoma vent through the aperture of the chest mount into the pneumostoma and securing the second pneumostoma vent to the chest mount; and

(c2) removing the second pneumostoma vent from the pneumostoma through the aperture of the chest mount and inserting a third pneumostoma vent through the aperture of the chest mount into the pneumostoma and securing the third pneumostoma vent to the chest mount.

5. The method of claim 4, wherein approximately one day passes between step (b) and step (c1) and between step (c1) and step (c2).

6. The method of claim 5, further comprising the step of:

(d) removing the chest mount from the chest of the patient after step (c2) and no sooner than 3 days after securing the chest mount to the chest of the patient.

7. The method of claim 6, further comprising the step of:

(e) replacing the chest mount with a second chest mount.

15. The method of claim 1, wherein approximately one day passes between step (c) and step (d) two or more times.

8. A method to control material entering and exiting a pneumostoma on a chest of a patient comprising:

(a) selecting a pneumostoma management device wherein the pneumostoma management device comprises a chest mount and a pneumostoma vent,

the chest mount having a first coupling adjacent an aperture in the chest mount,

the pneumostoma vent having a tube connected to a flow control device positioned such that material passing through the tube must pass through the flow control device, and

the pneumostoma vent having a second coupling adapted to releasably engage the first coupling;

(b) securing the chest mount to the chest of the patient such that aperture is aligned with the pneumostoma;

(c) inserting the tube of the pneumostoma vent through the aperture into the pneumostoma and engaging the first coupling with the second coupling such that the pneumostoma vent is secured in the pneumostoma and such that material entering or exiting the pneumostoma must pass through the tube and flow control device of the pneumostoma vent.

9. The method of claim 8, wherein the chest mount comprises an adhesive positioned to secure the chest mount to the chest of the patient and wherein step (b) comprises:

(b) securing the flange of the pneumostoma management device to the chest of a patient with the adhesive such that aperture is aligned with the pneumostoma.

10. The method of claim 8, wherein the chest mount comprises a hydrocolloid adhesive positioned to secure the chest mount to the chest of the patient and wherein step (b) comprises:

(b) securing the chest mount of the pneumostoma management device to the chest of a patient with a hydrocolloid adhesive such that aperture is aligned with the pneumostoma.

11. The method of claim 8, wherein the chest mount is adapted to conform to the chest of the patient and wherein step (b) comprises:

(b) securing the chest mount of the pneumostoma management device to the chest of a patient by conforming the chest mount to the chest of the patient such that aperture is aligned with the pneumostoma.

12. The method of claim 8, further comprising:

(d) disengaging the second coupling from the first coupling and removing the pneumostoma vent from the pneumostoma while leaving the chest mount secured to the chest of the patient.

13. The method of claim 8, further comprising:

(d) disengaging the second coupling from the first coupling and removing the pneumostoma vent from the pneumostoma while leaving the chest mount secured to the chest of the patient; and

(e) inserting a tube of a second pneumostoma vent through the aperture and engaging the first coupling with a second coupling of the second pneumostoma vent such that the second pneumostoma vent is secured in the pneumostoma and such that material entering or exiting the pneumostoma must pass through a tube and flow control device of the second pneumostoma vent.

14. The method of claim 12, further comprising the step of:

(f) removing the chest mount from the chest of the patient after step (e) and no sooner than two days after securing the chest mount to the chest of the patient.

16. The method of claim 13, further comprising the step of repeating steps (d) and (e).

17. The method of claim 16, further comprising the step of:

(f) removing the chest mount from the chest of the patient after said repeating of steps (d) and (e) and no sooner than three days after securing the chest mount to the chest of the patient.

18. The method of claim 17, further comprising the step of:

(g) replacing the chest mount with a second chest mount.

19. A method to control material entering and exiting a pneumostoma on a chest of a patient comprising:

(a) selecting a pneumostoma management device wherein the pneumostoma management device comprises a chest mount and a pneumostoma vent;

the chest mount having a first coupling adjacent an aperture in a flange;

the pneumostoma vent having a tube connected to a cap;

the tube connected to a flow control device positioned such that material passing through the tube must pass through the flow control device;

the cap having a second coupling that can be releasably engaged with the first coupling;

(b) securing the flange to the chest of the patient such that aperture is aligned with the pneumostoma;

(c) inserting the tube of the pneumostoma vent through the aperture and engaging the first coupling with the second coupling such that the pneumostoma vent is secured in the pneumostoma and such that material entering or exiting the pneumostoma must pass through the tube and flow control device of the pneumostoma vent.

20. The method of claim 19, wherein the flange comprises an adhesive positioned to secure the flange to the chest of the patient and wherein step (b) comprises:

(b) securing the flange of the pneumostoma management device to the chest of a patient with the adhesive such that aperture is aligned with the pneumostoma.

21. The method of claim 19, wherein the flange comprises a hydrocolloid adhesive positioned to secure the flange to the chest of the patient and wherein step (b) comprises:

(b) securing the flange of the pneumostoma management device to the chest of a patient with a hydrocolloid adhesive such that aperture is aligned with the pneumostoma.

22. The method of claim 19, wherein the flange is adapted to conform to the chest of the patient and wherein step (b) comprises:

(b) securing the flange of the pneumostoma management device to the chest of a patient by conforming the flange to the chest of the patient such that aperture is aligned with the pneumostoma.

23. The method of claim 19, further comprising:

(d) disengaging the second coupling from the first coupling and removing the pneumostoma vent from the pneumostoma while leaving the chest mount secured to the chest of the patient.

24. The method of claim 19, further comprising:

(d) disengaging the second coupling from the first coupling and removing the pneumostoma vent from the pneumostoma while leaving the chest mount secured to the chest of the patient; and

(e) inserting a tube of a second pneumostoma vent through the aperture and engaging the first coupling with a second coupling of the second pneumostoma vent such that the second pneumostoma vent is secured in the pneumostoma and such that material entering or exiting the pneumostoma must pass through a tube and flow control device of the second pneumostoma vent.